Tue, Jul 22, 2014, 3:42 PM EDT - U.S. Markets close in 18 mins.


% | $
Click the to save as a favorite.

Curis, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • docihi docihi Jun 30, 2011 12:42 PM Flag


    I really like your enthusiasm, but competition must be taken into account for any company/stock. This is one of the many reasons why biotech companies and their stockholders are in such a high risk/reward business.

    A quick search of clinicaltrials.gov shows that there are 3962 trials aimed at some form or particular condition (breast cancer), in addition to combinations of drugs, etc. The website lists 82 Roche trials for breast cancer. I do not know how current the lists are.

    The only breast cancer study in which 0449 was used (IN COMBINATION WITH ANOTHER DRUG - RO4929097) was reported suspended on 6/21/2011 due to the potential risk of severe or life-threatening arrhythmia. There is one other study being conducted with the same combination, but it is not listed as being suspended. As we know, there are 25+ studies using 0449 and they are not listed as being suspended. Also, there are many RO4929097 studies that are still listed as current (not suspended). I will not speculate on why the study was suspended. I can't find a comment from neither Curis nor Roche on this. If the safety issue was specifically due to 0449 the stock would be practically worthless now.


1.755+0.015(+0.86%)3:41 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.